Company
xCystence Bio
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Developing targeted protein degrader drugs to treat polycystic kidney disease.
Loading relationship preview
Company
Record updated 28 September 2026
Developing targeted protein degrader drugs to treat polycystic kidney disease.
A first look at xCystence Bio’s connections in the VC Catalog database. Sign in with Google to open the interactive map.
Investor VC firms in this preview
VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.